• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,022
92
66
63
53

COUNTRY

60
20
11
8
6

CATEGORIES

  • 85
  • 124
  • 67
  • 65
  • 37
  • 37
  • 12
  • 12
  • 11
  • 18

PRICE

552
766
1,729
2,753

PUBLISHED

61
98
589
2,753

PRODUCT TYPE

2,645
89
9
6
2
2

Oncology

(2,753 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM
Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids - Product Thumbnail Image

Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids

The isolation and characterisation of CTCs and CNAs are two of the fastest growing areas of research in the cancer field. Growth is also being seen in the translation of this research into diagnostic...

September 2014
FROM

Global Pancreatic Cancer Market 2014-2018

About Pancreatic Cancer Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine...

October 2014
FROM

Global Non-small Cell Lung Cancer Market 2014-2018

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer...

September 2014
FROM
The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) - Product Thumbnail Image

The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness...

January 2015
FROM

Thyroid Cancer: Disease and Pipeline Analysis

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the thyroid cancer market not available elsewhere. This report gives an overview of...

August 2014
FROM
IVD Procedure Volumes and Pricing Analysis IVD Procedure Volumes and Pricing Analysis - Product Thumbnail Image

IVD Procedure Volumes and Pricing Analysis

IVD Procedure Volumes and Pricing Analysis Clinical laboratory medicine plays an integral role in healthcare and disease management, as it estimated that approximately 80% of physician’s diagnoses...

January 2015
FROM

Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management

Cancer diagnostics based on measuring biomarkers in tissue samples has already in the past decade provided revolutionary advances in diagnosis, prognosis, and therapy selection. A major drawback of...

February 2015
FROM
The World Market for Tissue Diagnostics and Cell-Based Diagnostics (Histology and Cytology Tests, in situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other The World Market for Tissue Diagnostics and Cell-Based Diagnostics (Histology and Cytology Tests, in situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other - Product Thumbnail Image

The World Market for Tissue Diagnostics and Cell-Based Diagnostics (Histology and Cytology Tests, in situ hybridization (ISH), HPV Tests, Flow Cytometry, Digital Pathology/Image Cytometry, Hematology Cell Assays, Immunohistochemistry, CTC and Other

The field of tissue diagnostics and cell-based diagnostics includes many traditional technologies, some of which have been used for decades.  In addition many new technologies are now being applied...

November 2014
FROM

The Market for Personalized Gene Therapy Treatments for Cancer

The Market for Personalized Gene Therapy Treatments for Cancer This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for...

December 2014
FROM
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

July 2015
FROM
North American Radiotherapy Market Outlook - Forecast (2014-2020) North American Radiotherapy Market Outlook - Forecast (2014-2020) - Product Thumbnail Image

North American Radiotherapy Market Outlook - Forecast (2014-2020)

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and...

June 2015
FROM
Europe Radiotherapy Market Outlook - Forecast (2014-2020) Europe Radiotherapy Market Outlook - Forecast (2014-2020) - Product Thumbnail Image

Europe Radiotherapy Market Outlook - Forecast (2014-2020)

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and...

June 2015
FROM
Middle East Radiotherapy Market Outlook - Forecast (2014-2020) Middle East Radiotherapy Market Outlook - Forecast (2014-2020) - Product Thumbnail Image

Middle East Radiotherapy Market Outlook - Forecast (2014-2020)

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and...

June 2015
FROM

U.S. Thyroid Cancer Market: Trends and Opportunities (2015 – 2019)

The report “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail...

April 2015
FROM

EpiCast Report: Prostate Cancer - Epidemiology Forecast to 2023

EpiCast Report: Prostate Cancer - Epidemiology Forecast to 2023 Summary Prostate cancer is a malignant tumor that forms in the tissues of the prostate, a gland in the male reproductive system found...

April 2015
FROM

EpiCast Report: Melanoma - Epidemiology Forecast to 2023

EpiCast Report: Melanoma - Epidemiology Forecast to 2023 Summary Melanoma of the skin is a malignant neoplasm of melanocytes and is a significant source of morbidity and mortality worldwide. The...

April 2015
FROM

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy This linkage could be important in the therapeutic...

June 2014
FROM

Global Breast Cancer Market 2014-2018

About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically,...

June 2014
FROM

Global Non-Melanoma Skin Cancer Market 2014-2018

About Non-melanoma Skin Cancer Non-melanoma skin cancer is one of the most common types of cancer in the world It develops in the upper layers of the skin, but not in melanocytes There are two types...

May 2014
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)